President’s Malaria Initiative: Private Sector Distribution of Artemisinin-Based Combination Therapies in Liberia


In Liberia, it is estimated that at least 46% of the population accesses antimalarials through the private sector. Quality-assured ACTs, however, are generally more expensive than older antimalarials; therefore, the majority of these outlets still stock chloroquine and other monotherapies. According to the 2010–15 national malaria strategic plan, MOHSW is committed to increasing access to prompt and effective treatment.

, , , , , ,